Activist investor NexPoint threatens to block Paratek's $462M sale

Paratek Pharmaceuticals' annual meeting is set for July 6, but fireworks are already exploding over the company’s attempt to sell out to investment firms Novo Holdings and Gurnet Point for $462 million.